Wall Street Analysts Upgrade Humana, Downgrade Las Vegas Sands
On July 30, Wall Street analysts issued several notable upgrades and downgrades across various sectors. Among the top upgrades was Leerink's move to upgrade Humana (HUM) from Market Perform to Outperform with a $513 price target, citing an attractive valuation based on projected earnings power in 2028. Piper Sandler also upgraded HUM to Overweight from Neutral, raising its price target significantly. In contrast, Argus downgraded Las Vegas Sands (LVS) to Hold from Buy due to ongoing challenges including a weak Chinese economy and uncertain recovery pace in Singapore affecting VIP gaming demand. Other upgrades included Bloom Energy (BE), Sprouts Farmers Market (SFM), uniQure (QURE), and Core Scientific (CORZ). Downgrades also affected Procter & Gamble (PG) and Capricor Therapeutics (CAPR), among others, due to weak earnings or regulatory setbacks.
Tickers: $CAPR $CORZ $HUM $LVS $PG $QURE $SFM
Topics: analyst calls price targets stock upgrades